Showing results (1-10 of 69) with videos related to
Sort By:
Pageof 7
Current Opinion in Investigational Drugs (London, England : 2000)|June 19, 2004
New nitric oxide-donating drugs for the treatment of airway diseasesVincent Lagente, Charles AdvenierJournal of Molecular and Cellular Cardiology|October 13, 2009
Role of matrix metalloproteinases in the inflammatory process of respiratory diseasesVincent Lagente, Elisabeth BoichotPharmacological Research|January 19, 2019
Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitisWaleska Dornas, Vincent LagenteDrug Metabolism Reviews|October 25, 2019
Ethanol and its metabolites: update on toxicity, benefits, and focus on immunomodulatory effectsBrendan Le Daré, Vincent Lagente, Thomas GicquelExpert Opinion on Therapeutic Targets|February 25, 2009
Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseasesVincent Lagente, Catherine Le Quement, Elisabeth BoichotPresse Medicale (Paris, France : 1983)|February 17, 2016
[The NLRP3 inflammasome: Physiopathology and therapeutic application]Thomas Gicquel, Sacha Robert, Tatiana Victoni, et al.Fundamental & Clinical Pharmacology|November 26, 2016
Purinergic receptors: new targets for the treatment of gout and fibrosisThomas Gicquel, Brendan Le Daré, Elisabeth Boichot, et al.Oxidative Medicine and Cellular Longevity|February 25, 2021
Oxidative Imbalance as a Crucial Factor in Inflammatory Lung Diseases: Could Antioxidant Treatment Constitute a New Therapeutic Strategy?Tatiana Victoni, Emiliano Barreto, Vincent Lagente, et al.Memorias Do Instituto Oswaldo Cruz|June 18, 2005
Macrophage elastase (MMP-12): a pro-inflammatory mediator?Soazig Nénan, Elisabeth Boichot, Vincent Lagente, et al.International Immunopharmacology|May 15, 2007
Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosisBoris Manoury, Soizig Nénan, Isabelle Guénon, et al.Pageof 7